 BOSTON, Oct. 20, 2021 GLOBE NEWSWIRE -- Akouos, Inc. Akouos NASDAQ: AKUS, a precision genetic medicine company dedicated to developing potential gene therapies for individuals living with disabling hearing loss worldwide, today announced that Manny Simons, Ph.D., M.B.A., co-founder, president, and chief executive officer of Akouos, will participate in a presentation at the Jefferies Gene TherapyEditing Summit on Wednesday, October 27 at 9:30 a.m. EDT. 